EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cardiac Valve Repair and Replacement: Are Transcatheter Options Here to Stay?

Samuel Rustem Panday, Fatemeh Habibi Nameghi, Federico Giacobbe, Mehdi Eskandari, Alexandros Papachristidis, Kevin O'Gallagher, Philip MacCarthy, Jonathan Byrne, Max Baghai

British Journal of Hospital Medicine · 20.05.2026 · 87 (5)

DOI: 10.31083/bjhm54067 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, online erschienen am 20.05.2026. Verfasst von Samuel Rustem Panday und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, King's College Hospital, SE5 9RS London, UK. Hauptthemen laut MEDLINE: Heart Valve Diseases, Heart Valve Prosthesis Implantation, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Valvular heart disease (VHD) affects millions worldwide and remains a major cause of morbidity and mortality, placing a substantial and growing burden on healthcare systems. Over the past two decades, transcatheter therapies have emerged to meet this challenge, transforming the management of aortic, mitral, and tricuspid valve disease. Initially developed for inoperable or high-risk surgical patients, procedures such as transcatheter aortic valve implantation (TAVI) and mitral transcatheter edge-to-edge repair (M-TEER) are now routinely offered across a broader risk spectrum. More recently, tricuspid therapies, including tricuspid transcatheter edge-to-edge repair (T-TEER) and transcatheter valve replacement (TTVR), have emerged to address a significant unmet clinical need. With transcatheter interventions becoming more widely available, clinicians across general and acute medical specialities are increasingly likely to encounter patients before and after these procedures. Familiarity with these therapies will support better decision-making and coordinated care. This review summarises the evolution of transcatheter valve therapy, its role alongside surgery, and the evidence supporting its use. Surgery remains the gold standard for younger or low-risk patients, particularly where long-term durability is essential. Transcatheter therapies now offer safe and effective treatment for older patients, including those with frailty or significant comorbidity, supported by landmark trials, which have demonstrated favourable clinical outcomes in carefully selected populations and underpinned guideline endorsement across risk categories. The importance of the multidisciplinary Heart Team is emphasised, ensuring treatment decisions reflect individual anatomy, comorbidity burden, life expectancy, and procedural risk. As device technology, imaging, and procedural expertise continue to advance, the integration of surgical and transcatheter approaches will support more individualised care and broaden access to definitive treatment for patients across the clinical spectrum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve DiseasesHeart Valve Prosthesis ImplantationTranscatheter Aortic Valve ReplacementHumansCardiac Catheterization

Stichwörter der Autor:innen

cardiac surgical proceduresheart valve diseasesheart valve prosthesis implantationmitral valve insufficiencytranscatheter aortic valve replacementtricuspid valve insufficiency

Autor:innen und Institutionen

  • Department of Cardiology, King's College Hospital, SE5 9RS London, UK.
  • School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, SE5 9RS London, UK.
  • Department of Cardiology, Royal Brompton Hospital, SW3 6NP London, UK.
  • Department of Cardiothoracic Surgery, King's College Hospital, SE5 9RS London, UK.

Zitieren

APA

Panday, S. R., Nameghi, F. H., Giacobbe, F., Eskandari, M., Papachristidis, A., O'Gallagher, K., MacCarthy, P., Byrne, J., & Baghai, M. (2026). Cardiac Valve Repair and Replacement: Are Transcatheter Options Here to Stay?. British Journal of Hospital Medicine, 87(5). https://doi.org/10.31083/bjhm54067

Vancouver

Panday SR, Nameghi FH, Giacobbe F, Eskandari M, Papachristidis A, O'Gallagher K, et al. Cardiac Valve Repair and Replacement: Are Transcatheter Options Here to Stay?. British Journal of Hospital Medicine. 2026;87(5). doi:10.31083/bjhm54067

BibTeX
@article{Panday2026,
  author = {Panday, Samuel Rustem and Nameghi, Fatemeh Habibi and Giacobbe, Federico and Eskandari, Mehdi and Papachristidis, Alexandros and O'Gallagher, Kevin and MacCarthy, Philip and Byrne, Jonathan and Baghai, Max},
  title = {Cardiac Valve Repair and Replacement: Are Transcatheter Options Here to Stay?},
  journal = {British Journal of Hospital Medicine},
  year = {2026},
  volume = {87},
  number = {5},
  doi = {10.31083/bjhm54067}
}
Kostenlos starten →